Notice to the Market

The Company (B3: AALR3) hereby communicates to its shareholders and to the market in general that the rating agency Fitch Ratings has upgraded the outlook of Alliar‘s corporate rating, maintaining the rating of ‘A+(bra)‘, with an improvement of the outlook to stable.

According to Fitch‘s report, the revision of the Outlook includes the resumption of the company‘s operational cash generation and positive free cash flows (FCFs) starting in 2021, supported by the growth of the new business areas and the clinical analysis segment.

The report also attributes that Alliar‘s rating is driven by the healthcare industry‘s low to moderate risk, with positive fundamentals in the medium to long term.

Click here to access Fitch‘s press release.

In conclusion, Alliar reinforces that the hiring and disclosure of the rating reflect the Company‘s commitment to the best governance practices and to transparency in the relationship with its shareholders and creditors.

Săo Paulo, April 16,, 2021

For more information, access our IR website.

IR Contact

Gabriel Rozenberg
Investor Relations Officer